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Neural stem cellA ligand-activated transcription factor aryl hydrocarbon receptor (AhR) is recently revealed to play a key role in
embryogenesis and tumorigenesis (Feng et al. [1], Safe et al. [2]) and 2-(1′H-indole-3′-carbonyl)-thiazole-4-car-
boxylic acidmethyl ester (ITE) (Song et al. [3]) is an endogenous AhR ligand that possesses anti-tumor activity. In
order to gain insights into how ITE acts via the AhR in embryogenesis and tumorigenesis, we analyzed the
genome-wide transcriptional proﬁles of the following three groups of cells: the human glioblastoma U87 paren-
tal cells, U87 tumor sphere cells treatedwith vehicle (DMSO) and U87 tumor sphere cells treated with ITE. Here,
weprovide the details of the sample gathering strategy and show the quality controls and the analyses associated
with our gene array data deposited into the Gene Expression Omnibus (GEO) under the accession code of
GSE67986.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Speciﬁcationsrganism/cell
line/tissueHuman glioblastoma U87 MGx Male
quencer or
array typeAffymetrix Human Gene Expression Array GPL15207ata format Raw data (CEL ﬁles)
xperimental
factorsparental U87 cells, U87 tumor sphere cells treated with vehicle
(DMSO) and U87 tumor sphere cells treated with ITExperimental
featuresIsolation and gene expression proﬁling of U87 cells grown in
neural stem cell medium supplemented with ITEonsent N/A
mple source
locationHangzhou, China1. Direct link to deposited data
Deposited data can be found at: http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE67986. This is an open access article under2. Experimental design, materials and methods
2.1. Experimental design
To determine the global transcriptional effects of ITE (Song et al. [3])
on parental and tumor sphere U87 cells, mRNA samples from three ex-
perimental groups (i.e., parental U87 cells, U87 tumor sphere cells treat-
ed with vehicle (DMSO) and U87 tumor sphere cells treated with ITE)
were analyzed by Affymetrix Human Gene Expression Array.2.2. Sample culture and isolation procedure
For parental U87 sample, cells were cultured in DMEM (Invitrogen
21063-029, containing 16 mg/L L-tryptophan) supplemented with 10%
fetal bovine serum (GIBCO 10099 or Pufei 1101-500). For tumor sphere
assay (Ledur et al. [4]), U87 cells were plated at a density of 30,000 cells/
ml with neural stem cell (NSC) medium which contains DMEM/F-12
(Corning R10-092-CV) supplemented with 1% (v/v) PS, 2% (v/v) B-
27® Supplement Minus Vitamin A, 20 ng/mL EGF, 20 ng/mL bFGF and
10 ng/mL LIF to allow tumor sphere formation. U87 tumor sphere cells
were cultured in NSCmedium and treatedwith either 0.01% DMSO (ve-
hicle) or 10 μM ITE for 5 days with the ITE being replenished every 12 h.
After treatment, U87 tumor spheres were harvested and subjected to
microarray analysis.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Brieﬂy, RNAwas extracted fromU87parental and tumor sphere cells
by TRIzol method according to the manufacturer's instructions. Reverse
transcription to the ﬁrst-strand cDNA was primed with T7 oligo (dT)
primer to synthesize cDNA containing a T7 promoter sequence.
Second-strand cDNA synthesis converts the single-stranded cDNA intoFig. 1. Quality controls and analysis of microarrays. A) boxplots of log2 transformed probe inte
processing. C) Principal component analysis. The percentage of variability explained by each com
and Ward's aggregation showed the clustering of the replicates and the close genetic relationsa double-stranded DNA (dsDNA) template for transcription. The reac-
tion employs DNA polymerase and RNase H to simultaneously degrade
the RNA and synthesize the second-strand cDNA. In vitro transcription
to synthesize biotin-modiﬁed aRNA with IVT Labeling Master Mix gen-
erates multiple copies of biotin-modiﬁed aRNA from the double-
stranded cDNA templates. aRNA puriﬁcation removes unincorporated
NTPs, salts, enzymes, and inorganic phosphate to improve the stabilitynsity after RMA processing. B) Histograms of log2 transformed probe intensity after RMA
ponent is indicated in brackets. D)Hierarchical clustering by Pearson correlation distance
hip between three subsets.
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pares the target for hybridization to GeneChip® 3′ expression arrays.
Above procedures were carried out by GeneChip IVT express Kits
(Affymetrix: 901229). The hybridization was carried out by GeneChip
Hybridization, Wash, and Stain kit (affymetrix: 900720). The arrays
were scanned at 570 nm with a confocal scanner from Affymetrix.
2.4. Quality control and data analysis
Analysis of the arrays was performed using the Partek GS 6.5. Nor-
malization of the array was performed using a robust multiarray analy-
sis (RMA). A p-value cut off of 0.05 was used to ﬁlter genes that were
signiﬁcantly expressed between the two samples. A fold change of 2
was used as a criterion for primary selection for differentially expressed
genes. Boxplot and histograms of RMA processed probe intensities
across all arrays shown in (Fig. 1A and B) indicated similar distribution
of signal intensities between arrays. Principal component analysis (PCA,
Fig. 1C) and hierarchical clustering (HC) by Pearson correlation distance
and Ward's aggregation (Fig. 1D) were performed after selection of
probes with a differential expression in any combination of array N1.5.Acknowledgments
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